Federal contract award
75A50122C00080
VENATORX PHARMACEUTICALS: ANTIBIOTIC FOR AMR AND BIOTHREAT PATHOGENS
Award details
Obligations, current value and potential value describe different measures; they are never added together.
| Field | Reported value |
|---|---|
| Agency | Department of Health and Human Services |
| Office | BARDA - ASPR / DAAPPO / BARDA DCMA |
| NAICS | 541714 — Research and Development in Biotechnology (except Nanobiotechnology) |
| PSC | 6505 — Drugs and Biologicals |
| Parent award / vehicle | Not reported |
| Set-aside | NO SET ASIDE USED. |
| Pricing type | COST PLUS FIXED FEE |
| Obligations | $72.1M |
| Current contract value | $72.1M |
| Potential contract value / ceiling | $318.6M |
| Start date | Sep 27, 2022 |
| Current end date | Dec 31, 2028 |
| Potential end date | Sep 22, 2032 |
| Latest award activity | May 13, 2026 |
| Source loaded | Sep 19, 2026 |
Funding and modification history
Showing the latest 2 of 2 loaded transactions. Negative values are deobligations.
| Date | Modification | Obligation change | Description |
|---|---|---|---|
| May 13, 2026 | P00006 | $0 | THE PURPOSE OF THIS MODIFICATION IS TO REPORT INFORMATION VIA FPDS FOR CONTRACTS BEING ALIGNED WITH THE PRESIDENTIAL COST SAVINGS INITIATIVE. EOI: RADICAL TRANSPARENCY ABOUT WASTEFUL SPENDING |
| Nov 25, 2024 | P00005 | $0 | THE PURPOSE OF THIS MODIFICATION IS TO UPDATE ARTICLES I.1 FEDERAL ACQUISITION REGULATION (FAR) (48 CFR CHAPTER 1) CLAUSES, 52.204-14 SERVICES CONTRACT REPORTING REQUIREMENTS. |
Estimated positioning window
Sep 22, 2031 – Mar 22, 2032
45/100
Why this recompete signal
Contract timing and recorded acquisition signals at the time of calculation.
Stored score: 45/100. Available recorded signals: 40 points.
- Contract end 2032-09-22 (2152 days from calculation)
- +5 points
- 25 historical awards in this buyer and category group
- +15 points
- 2 recorded award transactions
- +5 points
- Latest award action: 2026-05-13
- +5 points
- Parent award identifier recorded
- +0 points
- Solicitation identifier recorded
- +10 points
- Linked official forecast
- +0 points
- Calculated on
- 2026-11-01 10:17:53.997580+00:00
The historical group combines buyer, NAICS, and PSC. Multiple awards in this group do not by themselves establish repeated competitions.
Rule-based research score; it does not measure your chance of winning.
This older calculation does not retain a complete reproducible breakdown. Missing or changed inputs are not assigned invented points: Original award-value bonus input.
Recompete score calculated Nov 1, 2026.
Buyer contacts from matching notices
Matched on exact award/solicitation identifier and awarding agency. Source dates describe the notice, not current contact verification.
| Contact | Role | Published contact methods | Evidence | Source date |
|---|---|---|---|---|
| Jill Johnson, Contracting Officer | Contact | jill.johnson@hhs.gov 2028161148 | Source | Feb 16, 2022 |
| Kevin Restrepo | Contact | kevin.restrepo@hhs.gov 2028152367 | Source | Feb 16, 2022 |
| Jill Johnson, Contracting Officer | Contact | jill.johnson@hhs.gov 2028161148 | Source | Jan 20, 2022 |
| Kevin Restrepo | Contact | kevin.restrepo@hhs.gov 2028152367 | Source | Jan 20, 2022 |
| Jill Johnson, Contracting Officer | Contact | jill.johnson@hhs.gov 2028161148 | Source | Dec 16, 2021 |
| Kevin Restrepo | Contact | kevin.restrepo@hhs.gov 2028152367 | Source | Dec 16, 2021 |
Research next steps
- Check the linked forecast or SAM for a confirmed solicitation and current timing.
- Verify whether remaining options may extend performance beyond the current end date.
- Check the stated set-aside against the solicitation and current certifications.
- Review the award scope and buyer evidence before making a bid/no-bid decision.